Previous studies have shown that DENND2D acts as a tumor suppressor gene in various cancers, including hepatocellular carcinoma [50], non‐small cell lung cancer [51], and esophageal squamous cell carcinoma [52]. Here, DENND2D is linked to hepatocellular carcinoma.